Roche — Fact Sheet (May 2020)

2 slides from Roche's fact sheet, May 2020

Slide 1: Immunoassay for the qualitative detection of antibodies against SARS-CoV-2
Ordering information Product Material configuration Material number Elecsys® Anti-SARS-CoV-2 Elecsys ® Anti-SARS-CoV-2 a) 200 tests 09 203 095 190 Immunoassay for the qualitative detection Elecsys Anti-SARS-CoV-2 300 tests 09 203 079 190 of antibodies against SARS-CoV-2 ® b) Diluent MultiAssay* a) 2
Slide 2: Immune Response, Test Principle and Performance Data
Depending on the applied method, seroconversion is observed Elecsys® Anti-SARS-CoV-2 is an immunoassay for the in vitro Clinical sensitivity33 after a median of 10 – 13 days after symptom onset for IgM and qualitative detection of antibodies (including IgG) to SARS-CoV-2 A total of 204 samples from